FABP5 and prostate cancer: GW0742 induced the expression of FABP5 both in the absence and in the presence of cycloheximide (Figure 3(a)), indicating that the effect did not require de novo protein synthesis raises the possibility that FABP5 is a direct target gene for PPARβ/δ in PC3M prostate cancer cells.